Lumasiran

Category: Genetic Disorders



Lumasiran Overview

Lumasiran, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1).[4][2][5] The most common side effects include injection site reactions and abdominal pain.[2] Lumasiran is a double-stranded small interfering ribonucleic acid (siRNA) that reduces levels of glycolate oxidase (GO) enzyme by targeting the HAO1 messenger ribonucleic acid (mRNA) in hepatocytes through RNA interferenc...

Read more Lumasiran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lumasiran

Recent Lumasiran Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lumasiran
  • Solution: 94.5mg/0.5ml, 94.5mg/0.5ml (94.5mg/0.5ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Lumasiran or a similar ingredient: (1 result)